Toms Capital disclosed a top-five equity position in Devon Energy (NYSE: DVN) this week, marking the second activist stake revealed since the company closed its $12 billion all-stock merger with Coterra Energy in late March. The firm joins Kimmeridge Energy Management in what is now a coordinated pressure campaign on management during the integration window.
The exact size of Toms Capital's stake was not disclosed in the initial filing, but top-five language in a company with $18.3 billion in market capitalization implies a position north of $800 million at current pricing. Devon shares trade at $38.12, down 14% since the Coterra deal closed on March 31, underperforming the XLE energy sector ETF by 9 percentage points over the same stretch. Kimmeridge, which first disclosed its position in mid-April, holds approximately 3.8% of outstanding shares and has already requested board representation.
The timing matters. Activist campaigns typically launch during one of three windows: distress, transition, or undervaluation. This is a transition play. Devon management guided to $350 million in annual synergies from the Coterra combination, with 65% expected to hit within the first twelve months. That synergy clock started April 1. Toms Capital and Kimmeridge are now on record before the first quarterly earnings print that will include merged operations, scheduled for May 7. The message to CEO Rick Muncrief is clear: prove the thesis fast, or expect interference on capital allocation and board composition.
The combined entity now controls 1.1 million net acres across the Delaware Basin and Anadarko Basin, with pro forma production guidance of 930,000 barrels of oil equivalent per day. The operational logic is sound. The financial logic is under scrutiny. Devon's free cash flow yield sits at 11.2%, a 340-basis-point discount to peers including Diamondback Energy and ConocoPhillips, despite comparable asset quality. That gap is the activist wedge. If synergies lag or if management fails to accelerate shareholder returns through buybacks or special dividends, both Toms and Kimmeridge have the positioning to force board changes by the September annual meeting.
Allocators should watch three data points. First, the May 7 earnings call, specifically management commentary on synergy capture velocity and updated free cash flow guidance for the back half of 2025. Second, any additional 13D filings from Toms Capital or Kimmeridge in the next 30 days, which would signal coordination or escalation. Third, Devon's buyback pace. The company has $2 billion remaining under its current authorization, but has only deployed $180 million year-to-date. Accelerated repurchase activity before the earnings print would indicate management is front-running activist demands.
The stock now trades at 4.2x forward EBITDA, a 15% discount to the integrated E&P peer group. If Toms Capital and Kimmeridge succeed in forcing synergy acceleration or capital return discipline, that multiple gap closes. If they fail, expect proxy season by autumn.